The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.
The U.S. Federal Trade Commission (FTC) has slammed pharmacy benefit managers (PBMs) owned by UnitedHealth ($UNH), CVS Health ($CVS) and Cigna ...
The Federal Trade Commission said three top pharmacy suppliers made profits of 7,700 percent on a lifesaving hypertension ...
The Federal Trade Commision (FTC) found prescription benefits managers like UnitedHealth's OptumRX have gained $7.3B from ...
(Bloomberg) -- Units of CVS Health Corp., Cigna Group and UnitedHealth ... organ transplants and other conditions and procedures, the FTC said. The report demonstrates how pharmacy benefit ...
Investing.com -- Shares of CVS Health Corp (NYSE:CVS), Cigna (NYSE:CI) Group, and UnitedHealth Group Inc (NYSE:UNH) were down around 1% after the Federal Trade Commission (FTC) accused their ...
CVS Health, UnitedHealth Group and Cigna share prices dipped midday after the FTC released its report, but each company rebounded and was up slightly when the New York Stock Exchange closed Tuesday.
Shocking revelations from a Federal Trade Commission, or FTC, investigation have exposed how three major prescription benefit managers, or PBMs, ...
News Nation on MSN13d
UnitedHealth marked up lifesaving drugs as much as 1,000%: FTCBetween 2017 and 2022, UnitedHealth Group’s Optum, Cigna’s Express Scripts and CVS Health’s CVS Caremark marked up their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback